2m 2m 2m 2m 2m 2m 2m
Cross Ctry Hlthc (CCRN)
NASDAQ
$13.19-$0.004 (-0.03%)
Price as of Jun 23, 2026 5:00 PM EDT- $425.5MMarket Cap
- 0.30%1-Year Change
- Medical Care FacilitiesIndustry
Cross Ctry Hlthc (CCRN)
$13.19-$0.004 (-0.03%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.1B -21.56% | 1.3B -33.46% | 2.0B -28.04% | 2.8B +67.39% | |
Cost of Revenue | 840.7M -21.41% | 1.1B -31.83% | 1.6B -27.98% | 2.2B +67.40% | |
Gross Profit | 213.6M -22.13% | 274.3M -39.11% | 450.4M -28.24% | 627.7M +67.38% | |
Sales and Marketing Expense | 200.7M -14.01% | 233.4M -22.31% | 300.4M -7.35% | 324.2M +50.59% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 16.8M -7.73% | 18.2M -0.80% | 18.3M +45.89% | 12.6M +27.65% | |
Total Operating Expenses | 1.1B -16.33% | 1.4B -28.64% | 1.9B -24.73% | 2.5B +64.80% | |
Operating Profit | -84.4M +479.92% | -14.6M -112.91% | 112.7M -58.73% | 273.1M +96.05% | |
Interest Income | 3.1M +52.63% | 2.0M N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -8.1M -43.76% | -14.4M +109.60% | |
Interest Income and Expense and Net | 3.1M +52.63% | 2.0M +125.33% | -8.1M -156.24% | 14.4M +109.60% | |
Total Nonoperating Income and Expense | -9,000 -101.49% | 605,000 +30,350.00% | -2,000 -100.15% | 1.3M +73.51% | |
Income before Taxes | -83.5M +473.71% | -14.6M -114.15% | 102.9M -59.86% | 256.3M +92.42% | |
Income Taxes | 11.3M +715.74% | -1.8M -106.09% | 30.3M -55.41% | 67.9M +5,527.20% | |
Extraordinary Items | 77.9M +2,595.67% | 2.9M +301.67% | 719,000 -87.15% | 5.6M +170.39% | |
Net Income | -94.9M +551.63% | -14.6M -120.04% | 72.6M -61.46% | 188.5M +42.77% | |
Net Income from Continuing Operations Applicable to Common | -83.5M +473.71% | -14.6M -114.15% | 102.9M -59.86% | 256.3M +92.42% | |
Basic EPS and Net Income | -2.93 +565.91% | -0.44 -121.26% | 2.07 -59.33% | 5.09 +41.39% | |
Diluted EPS and Net Income | -2.93 +565.91% | -0.44 -121.46% | 2.05 -59.16% | 5.02 +42.21% | |
Basic Weighted Average Shares | 32.4M -2.91% | 33.4M -5.06% | 35.2M -5.01% | 37.0M +0.88% | |
Diluted Weighted Average Shares | 32.4M -2.91% | 33.4M -5.91% | 35.5M -5.49% | 37.5M +0.39% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 108.7M +33.20% | 81.6M +377.55% | 17.1M +374.31% | 3.6M +247.88% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 108.7M +33.20% | 81.6M +377.55% | 17.1M +374.31% | 3.6M +247.88% | |
Total Current Assets | 293.6M -12.36% | 335.0M -19.31% | 415.2M -38.56% | 675.7M +32.94% | |
Accumulated Depreciation | 26.0M +34.92% | 19.3M +22.00% | 15.8M -10.60% | 17.7M -0.27% | |
Property and Plant and Equipment and Net | 27.8M -3.73% | 28.9M +5.53% | 27.3M +39.04% | 19.7M +24.18% | |
Total Long-Term Assets | 2.1M -63.54% | 5.8M -12.95% | 6.7M -39.93% | 11.1M -49.40% | |
Total Assets | 449.0M -23.81% | 589.3M -13.26% | 679.3M -28.33% | 947.8M +29.34% | |
Income Taxes Payable | 2.5M N/A | N/A N/A | N/A N/A | 20,000 -99.73% | |
Total Short-Term Debt | 0 N/A | 0 N/A | N/A N/A | 0 -100.00% | |
Total Current Liabilities | 77.8M -35.42% | 120.4M -18.97% | 148.6M -45.30% | 271.6M +35.98% | |
Total Long-Term Debt | N/A N/A | 148.7M N/A | 0 -100.00% | 148.7M -15.67% | |
Total Long-Term Liabilities | 1.7M -53.70% | 3.6M -15.46% | 4.2M +9.90% | 3.8M -72.16% | |
Total Liabilities | 126.1M -25.93% | 170.3M -17.30% | 205.9M -58.03% | 490.6M +12.71% | |
Retained Earnings | 123.2M -43.50% | 218.1M -8.52% | 238.4M +43.83% | 165.7M +828.95% | |
Total Stockholders Equity | 322.8M -22.95% | 419.0M -11.50% | 473.4M +3.54% | 457.2M +53.67% | |
Total Shares Outstanding | 31.7M -1.72% | 32.3M -6.13% | 34.4M -5.28% | 36.3M -1.95% | |
Cash Flow | |||||
Cash from Operating Activities | 48.3M -59.83% | 120.1M -51.66% | 248.5M +85.38% | 134.1M +256.57% | |
Capital Expenditures | 8.2M -6.35% | 8.7M -37.64% | 14.0M +59.05% | 8.8M +22.54% | |
Cash from Investing Activities | -8.2M -6.35% | -8.7M -36.74% | -13.8M -68.60% | -43.9M +28.87% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -13.0M -72.24% | -46.8M -78.82% | -221.2M +152.56% | -87.6M -173.55% | |
Financials Ratio | |||||
Gross Margin | 20.26% -0.73% | 20.41% -8.50% | 22.30% -0.29% | 22.36% -0.006% | |
Operating Margin | -8.01% +639.31% | -1.08% -119.41% | 5.58% -42.65% | 9.73% +17.12% | |
Return on Assets | -18.27% +696.22% | -2.29% -125.71% | 8.93% -60.19% | 22.43% -7.42% | |
Return on Equity | -25.57% +683.90% | -3.26% -120.90% | 15.61% -68.74% | 49.94% -14.52% | |
Revenue Growth | -21.56% -35.57% | -33.46% +19.33% | -28.04% -141.60% | 67.39% -32.91% | |
Current Ratio | 3.78 +35.71% | 2.78 -0.42% | 2.79 +12.33% | 2.49 -2.24% | |
Cash Ratio | 1.40 +106.27% | 0.68 +489.57% | 0.12 +764.66% | 0.01 +155.77% | |
Debt-to-Equity Ratio | N/A N/A | 0.36 N/A | N/A N/A | 0.33 -46.39% | |
Debt-to-Assets Ratio | N/A N/A | 0.25 N/A | N/A N/A | 0.16 -36.32% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow